Method of treating pancreatic cancer
US-2024415804-A1 · Dec 19, 2024 · US
US10561633B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10561633-B2 |
| Application number | US-201515329062-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 26, 2015 |
| Priority date | Jul 30, 2014 |
| Publication date | Feb 18, 2020 |
| Grant date | Feb 18, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood.
Opening claim text (preview).
The invention claimed is: 1. A method for reducing serotonin levels in a mammal in need thereof comprising orally administering to the mammal a dose of about 0.03 μg/kg to about 3 mg/kg of a compound selected from the group consisting of: a salt thereof, and mixtures thereof. 2. The method of claim 1 , wherein the compound is administered as an orally consumable medicament. 3. The method of claim 2 , wherein the orally consumable medicament comprises: (i) at least one compound selected from the group consisting of: a salt thereof, and mixtures thereof, (ii) at least one solid carrier, and (iii) one or more flavorings, with the proviso that the sum of components (i), (ii) and (iii), together with any further ingredients, is 100% by weight, based on the total amount of the medicament. 4. The method of claim 1 , wherein countercations of the salts are selected from the group consisting of ammonium, trialkylammonium, sodium, potassium, magnesium, calcium, and mixtures thereof. 5. The method of claim 1 , wherein the compound is administered as an orally consumable foodstuff consumed for nourishment or pleasure comprising: (i) at least one compound selected from the group consisting of: a salt thereof, and a mixture thereof, (ii) at least one solid carrier, and (iii) one or more flavorings, with the proviso that the sum of components (i), (ii) and (iii), together with any further ingredients, is 100% by weight, based on the total amount of the foodstuff. 6. The method of claim 1 , wherein the compound is administered as a food supplement comprising: (i) at least one compound selected from the group consisting of: a salt thereof, and mixtures thereof, (ii) at least one solid carrier, and (iii) one or more flavorings, with the proviso that the sum of components (i), (ii) and (iii), together with any further ingredients, is 100% by weight, based on the total amount of the food supplement. 7. The method of claim 2 , wherein the medicament is a tablet or capsule. 8. The method of claim 3 , wherein the at least one solid carrier is selected from silicone dioxide, gum Arabic, and a maltodextrin having a DE value in the range of 5 to 20. 9. The method of claim 3 , wherein the at least one solid carrier has a mean particle size of 30 to 300 mm and a residual moisture content of less than or equal to 5% by weight. 10. The method of claim 5 , wherein the at least one solid carrier is selected from silicone dioxide, gum Arabic, and a maltodextrin having a DE value in the range of 5 to 20. 11. The method of claim 5 , wherein the at least one solid carrier has a mean particle size of 30 to 300 μm and a residual moisture content of less than or equal to 5% by weight. 12. The method of claim 5 , wherein the foodstuff further comprises: (iv) one or more sweeteners. 13. The method of claim 12 , wherein the foodstuff further comprises: (v) one or more thickeners. 14. The method of claim 5 , wherein the foodstuff is chewing gum comprising a water-insoluble component and a water-soluble component.
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Other dairy products · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
not hydrogenated in the hetero ring, e.g. flavones · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.